Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554304 · ClinicalTrials.gov registry record · Phase 1
Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT03554304 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 60 participants.
The verdict
NCT03554304, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
Interventions
- DRUG WCK 5222
- DRUG IV placebo matched to WCK 5222 / Moxifloxacin IV solution
- DRUG Moxifloxacin 400-mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-02-09 |
| Est. Completion | 2017-10-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03554304
The ClinicalTrials.gov registry entry for NCT03554304 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wockhardt, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which WCK 5222 is the first listed.
NCT03554304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03554304 about?
NCT03554304 is a clinical study titled "Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers". A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
What is the current status of trial NCT03554304?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2017-02-09. Estimated completion is 2017-10-06.
What interventions are being tested in trial NCT03554304?
The interventions under investigation include: WCK 5222 (DRUG), IV placebo matched to WCK 5222 / Moxifloxacin IV solution (DRUG), Moxifloxacin 400-mg (DRUG).
Who is sponsoring clinical trial NCT03554304?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.